Ke Nan
Impact in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immune cells in cancer
Papers in
-
- RNA modifications and cancer 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Co-authors
- Zhaoyuan Chen (6 shared papers)Wankun Chen (5 shared papers)Mengdi Qu (6 shared papers)Changhong Miao (5 shared papers)Ziwen Zhong (9 shared papers)Juan P. Cata (1 shared paper)Hao Zhang (1 shared paper)Shan Yi (1 shared paper)
- Journals
- Frontiers in Immunology (2 papers)Acta Biochimica et Biophysica Sinica (2 papers)Cell Death Discovery (1 paper)Gut (1 paper)Biosensors (1 paper)
- Partner nations
- ChinaUnited StatesGreece
In The Last Decade
Ke Nan
18 papers receiving 365 citations
Peers
Comparison fields: 5 of 72
- Immunology 136
- Critical Care and Intensive Care Medicine 22
- Neurology 35
- Developmental Neuroscience 14
- Clinical Biochemistry 22
Countries citing papers authored by Ke Nan
This map shows the geographic impact of Ke Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Nan more than expected).
Fields of papers citing papers by Ke Nan
This network shows the impact of papers produced by Ke Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Nan. The network helps show where Ke Nan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Nan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 79 | |
| 2 | 2022 | 64 | |
| 3 | 2018 | 50 | |
| 4 | 2021 | 35 | |
| 5 | 2021 | 27 | |
| 6 | 2021 | 19 | |
| 7 | 2008 | 17 | |
| 8 | 2023 | 13 | |
| 9 | Surgery-induced downregulation of hippocampal sirtuin-1 contributes to cognitive dysfunction by inhibiting autophagy and activating apoptosis in aged mice. | 2020 | 12 |
| 10 | 2025 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2025 | 9 | |
| 13 | 2024 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2021 | 5 | |
| 16 | 2017 | 4 | |
| 17 | 2024 | 2 | |
| 18 | 2018 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Ke Nan
Ke Nan is a scholar working on Molecular Biology, Immunology, Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 23 papers that have together received 371 indexed citations. Recurring topics across this work include Intensive Care Unit Cognitive Disorders (4 papers), Ferroptosis and cancer prognosis (4 papers), Anesthesia and Neurotoxicity Research (4 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), RNA modifications and cancer (3 papers), Sepsis Diagnosis and Treatment (3 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Immunology (136 citations), Critical Care and Intensive Care Medicine (22 citations), Neurology (35 citations), Developmental Neuroscience (14 citations) and Clinical Biochemistry (22 citations). Ke Nan has collaborated with scholars based in China, United States and Greece. Frequent co-authors include Zhaoyuan Chen, Wankun Chen, Mengdi Qu, Changhong Miao, Ziwen Zhong, Juan P. Cata, Hao Zhang, Shan Yi, Shuainan Zhu and Yuan‐Xiang Tao. Their work appears in journals such as Frontiers in Immunology, Acta Biochimica et Biophysica Sinica, Cell Death Discovery, Gut and Biosensors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.